Authors:
MUNTER RG
YINNON AM
SCHLESINGER Y
HERSHKO C
Citation: Rg. Munter et al., INFECTIVE ENDOCARDITIS DUE TO STENOTROPHOMONAS (XANTHOMONAS) MALTOPHILIA, European journal of clinical microbiology & infectious diseases, 17(5), 1998, pp. 353-356
Authors:
LINK G
SAADA A
PINSON A
KONIJN AM
HERSHKO C
Citation: G. Link et al., MITOCHONDRIAL RESPIRATORY ENZYMES ARE A MAJOR TARGET OF IRON TOXICITYIN RAT HEART-CELLS, The Journal of laboratory and clinical medicine, 131(5), 1998, pp. 466-474
Citation: C. Hershko et al., DEFERIPRONE (L1) FAILS TO MOBILIZE IRON AND PROMOTES IRON CARDIOTOXICITY AT SUBOPTIMAL L1 IRON CONCENTRATIONS/, Blood, 90(10), 1997, pp. 33-33
Authors:
HERSHKO C
LINK G
SAADA A
PINSON A
KONIJN AM
Citation: C. Hershko et al., PATHOGENESIS OF TRANSFUSIONAL SIDEROSIS - MITOCHONDRIAL RESPIRATORY ENZYMES ARE A MAJOR TARGET OF IRON TOXICITY, Blood, 90(10), 1997, pp. 34-34
Authors:
RIVKIN G
LINK G
SIMHON E
CYJON RL
KLEIN JY
HERSHKO C
Citation: G. Rivkin et al., IRC011, A NEW SYNTHETIC CHELATOR WITH SELECTIVE INTERACTION WITH CATABOLIC RED-BLOOD-CELL IRON - EVALUATION IN HYPERTRANSFUSED RATS WITH HEPATOCELLULAR AND RETICULOENDOTHELIAL RADIOIRON PROBES AND IN IRON-LOADED RAT-HEART CELLS IN CULTURE, Blood, 90(10), 1997, pp. 4180-4187
Authors:
HALILIRUTMAN I
HERSHKO C
LINK G
RUTMAN AJ
SHAINBERG A
Citation: I. Halilirutman et al., INHIBITION OF CALCIUM ACCUMULATION BY THE SARCOPLASMIC-RETICULUM - A PUTATIVE MECHANISM FOR THE CARDIOTOXICITY OF ADRIAMYCIN, Biochemical pharmacology, 54(1), 1997, pp. 211-214
Citation: S. Zevin et al., HALOGENODERMA OF THE FOREARM CAUSED BY 2-CHLORODEOXYADENOSINE TREATMENT, American journal of hematology, 53(3), 1996, pp. 209-210
Citation: G. Link et al., ROLE OF IRON IN THE POTENTIATION OF ANTHRACYCLINE CARDIOTOXICITY - IDENTIFICATION OF HEART CELL MITOCHONDRIA AS A MAJOR SITE OF IRON-ANTHRACYCLINE INTERACTION, The Journal of laboratory and clinical medicine, 127(3), 1996, pp. 272-278
Citation: R. Ruchlemer et al., CHANGES IN THE NATURAL-HISTORY OF INVASIVE PULMONARY ASPERGILLOSIS INNEUTROPENIC LEUKEMIC PATIENTS, Israel journal of medical sciences, 32(11), 1996, pp. 1089-1092
Citation: C. Hershko et al., DEFEROXAMINE PREVENTS ANTHRACYCLINE CARDIOTOXICITY - ROLE OF IRON IN MITOCHONDRIAL INJURY, Blood, 88(10), 1996, pp. 273-273
Authors:
HERSHKO C
RIVKIN G
LINK G
SIMHON E
CYJON RL
KLEIN JY
Citation: C. Hershko et al., IRC11, A NEW SYNTHETIC CHELATOR WITH SELECTIVE INTERACTION WITH CATABOLIC RED-BLOOD-CELL IRON, Blood, 88(10), 1996, pp. 1951-1951
Authors:
MATES M
HEYD J
SOUROUJON M
BENSASSON A
MANNY N
HERSHKO C
Citation: M. Mates et al., THE HAEMATOLOGIST AS WATCHDOG OF COMMUNITY-HEALTH BY FULL BLOOD-COUNT, Quarterly Journal of Medicine, 88(5), 1995, pp. 333-339
Citation: B. Rudensky et al., FALSE-NEGATIVE D-DIMER TEST IN A PATIENT WITH DISSEMINATED INTRAVASCULAR COAGULATION, American journal of hematology, 48(4), 1995, pp. 295-295
Authors:
ALREFAIE FN
HERSHKO C
HOFFBRAND AV
KOSARYAN M
OLIVIERI NF
TONDURY P
WONKE B
Citation: Fn. Alrefaie et al., RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS, British Journal of Haematology, 91(1), 1995, pp. 224-229
Citation: C. Hershko, CONTROL OF DISEASE BY SELECTIVE IRON DEPLETION - A NOVEL THERAPEUTIC STRATEGY UTILIZING IRON CHELATORS, Bailliere's clinical haematology, 7(4), 1994, pp. 965-1000
Authors:
YINNON AM
HADASHALPERN I
SHAPIRO M
HERSHKO C
Citation: Am. Yinnon et al., THE CHANGING CLINICAL SPECTRUM OF LIVER-ABSCESS - THE JERUSALEM EXPERIENCE, Postgraduate medical journal, 70(824), 1994, pp. 436-439
Citation: C. Hershko et Zi. Cabantchik, CONTROL OF MALARIA BY DRUG-MEDIATED IRON DEPRIVATION, Israel journal of medical sciences, 30(11), 1994, pp. 840-845
Authors:
MEERKIN D
ASHKENAZI Y
GOTTSCHALKSABAG S
HERSHKO C
Citation: D. Meerkin et al., PLASMA-CELL DYSCRASIA WITH MARROW FIBROSIS - A REVERSIBLE SYNDROME MIMICKING AGNOGENIC MYELOID METAPLASIA, Cancer, 73(3), 1994, pp. 625-628
Authors:
HERSHKO C
HOFFBRAND AV
KOSARYAN M
OLIVIERI NF
ALREFAIE FN
TONDURY P
WONKE B
Citation: C. Hershko et al., RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS, Blood, 84(10), 1994, pp. 10000257-10000257
Authors:
HERSHKO C
MATES M
BENSASSON A
SOUROUJON M
HEYD J
Citation: C. Hershko et al., ROLE OF THE HEMATOLOGIST AS A WATCHDOG OF COMMUNITY-HEALTH THROUGH CBC SCREENING, Blood, 84(10), 1994, pp. 10000503-10000503